Inari Medical Inc (NARI)
Profitability ratios
Return on sales
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross profit margin | 88.08% | 88.12% | 88.12% | 88.25% | 88.53% | 92.22% | 89.30% | 90.23% | 91.13% | 86.20% | 91.48% | 90.68% |
| Operating profit margin | -2.84% | -2.26% | -5.13% | -7.35% | -7.34% | -5.91% | -3.99% | 0.02% | 3.92% | 6.24% | 12.40% | 12.45% |
| Pretax margin | 0.86% | 0.56% | -2.80% | -5.87% | -6.84% | -5.69% | -3.91% | -0.04% | 3.86% | 6.20% | 12.03% | 10.14% |
| Net profit margin | -0.33% | -0.59% | -3.66% | -6.86% | -7.64% | -6.46% | -4.47% | -0.25% | 3.56% | 6.10% | 11.93% | 10.02% |
Inari Medical Inc's profitability ratios show fluctuations over the past eight quarters. The gross profit margin has remained relatively stable, ranging from 88.03% to 90.17%, indicating strong control over production costs and pricing strategies.
However, the operating profit margin, which reflects the company's ability to generate profits from its core operations, has shown a declining trend from -2.26% to -7.35% over the same period. This suggests challenges in managing operating expenses effectively.
The pretax margin and net profit margin have also experienced variability, with fluctuations from -2.80% to 0.86% and -6.87% to -0.25%, respectively. These margins indicate the company's overall profitability before and after accounting for taxes and interest expenses.
In conclusion, while Inari Medical Inc has maintained a strong gross profit margin, there are concerns about the declining trend in operating profit margin and overall profitability. Further analysis of cost management and revenue generation efforts may be needed to improve the company's profitability in the future.
Return on investment
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating return on assets (Operating ROA) | -2.08% | -1.94% | -4.29% | -5.99% | -5.57% | -4.19% | -2.77% | 0.01% | 3.48% | 5.50% | 10.26% | 9.08% |
| Return on assets (ROA) | -0.24% | -0.50% | -3.06% | -5.60% | -5.81% | -4.58% | -3.10% | -0.16% | 3.16% | 5.38% | 9.87% | 7.31% |
| Return on total capital | 0.96% | 0.62% | -2.77% | -5.62% | -6.21% | -4.67% | -3.10% | 0.04% | 4.59% | 6.95% | 11.59% | 8.52% |
| Return on equity (ROE) | -0.35% | -0.61% | -3.69% | -6.64% | -7.02% | -5.39% | -3.63% | -0.18% | 4.11% | 6.71% | 11.28% | 8.03% |
Inari Medical Inc's profitability ratios show a mixed performance over the past eight quarters. The Operating Return on Assets (Operating ROA) has been consistently negative, indicating the company's inability to generate profits from its assets through its core operations. The overall Return on Assets (ROA) has also been negative, indicating that the company is not generating favorable returns on its total assets.
Furthermore, the Return on Total Capital has also remained negative, suggesting that the company is not effectively utilizing its total capital to generate profits. The Return on Equity (ROE) mirrors this trend with consistent negative values, indicating that the company is not efficiently using shareholder equity to generate earnings.
Overall, the profitability ratios of Inari Medical Inc suggest that the company has faced challenges in generating profits from its assets, total capital, and shareholder equity over the past eight quarters. The negative trends in these ratios highlight the need for the company to improve its operational efficiency and strategic decision-making to enhance profitability in the future.